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rats against infarction
ab ab c Marie Joyeux , Patrice Faure , Diane Godin-Ribuot , Serge Halimi , Asha Patel ,
ca a , * Derek M. Yellon , Pierre Demenge , Christophe Ribuot
a ´´ ´ Laboratoire de Pharmacologie Cardiovasculaire Experimentale-Biomolecules, Universite Joseph Fourier, U.F.R. de Pharmacie, Grenoble, France
b ´ Laboratoire de Biologie du Stress Oxydant, Universite Joseph Fourier, U.F.R. de Pharmacie, Grenoble, France
cThe Hatter Institute for Cardiovascular Studies, University College London Hospitals & Medical School, London, UK
Received 18 February 1999; accepted 14 April 1999
Abstract
Objective: Protection conferred by heat stress (HS) against ischaemia–reperfusion injury, in term of mechanical function and
myocardial necrosis, has been extensively studied. In contrast, the effects of disease states on this HS-induced cytoprotective response are
less known. Therefore, we investigated the effects of prior heat stress on the infarct size in the isolated heart and on the myocardial heat
stress protein (HSP) 72 synthesis, in a model of insulin-dependent diabetic rats. Methods: Three groups of animals were studied: D rats
were rendered diabetic by 55 mg/kg streptozotocin i.v. injection, DI rats received the same treatment plus a daily injection of insulin
started 2 weeks after and V rats received the vehicle of streptozotocin plus a daily injection of saline. Eight weeks later, D, DI and V rats
were either heat-stressed (428C for 15 min) or sham-anaesthetised. Twenty-four hours later, their hearts were isolated, perfused using the
Langendorff technique, and subjected to a 30 min occlusion of the left coronary artery followed by 120 min of reperfusion. Myocardial
HSP72 content was measured 24 h after HS or sham treatment using an electrophoresis coupled with a Western blot analysis. Results:
Infarct-to-risk ratio (I/R) was signiﬁcantly reduced in hearts from heat-stressed (11.762.0%) compared to sham (30.063.2%)Vrats. This
cardioprotection was not observed in hearts from D (I/R: 31.463.3 vs. 34.363.5%) and DI (I/R: 28.761.6 vs. 30.361.6%) rats. Risk
zones were similar between all experimental groups. The incidence of ventricular arrhythmias during ischaemia and reperfusion periods
was not different between the six experimental groups.Western blot analysis of the myocardial HSP72 content showed a comparable heat
stress-induced increase of this protein, in V, D and DI animals. Conclusion: These results demonstrate that myocardial protective effect
induced by heat stress could not extend to a pathological animal model like the diabetic rat and seems to be unrelated to the HSP72 level.
Further investigations are required to elucidate the precise role of the heat stress proteins in this adaptive response. Ó 1999 Elsevier
Science B.V. All rights reserved.
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1. Introduction hyperthermia, is associated with protection against is-
chaemia–reperfusion injury [3–6] and has been correlated
Heat stress (HS), as well as other environmental stres- to the degree of HS-induced ischaemic tolerance [7,8].
ses, is known to induce synthesis of heat stress proteins Although the cytoprotective response induced by heat
(HSP) which play an important role in the cell’s ability to stress is reasonably well known in non-pathological ani-
survive noxious stresses [1,2]. In particular, the myocardial mals, our knowledge of the effects of disease states on this
induction of HSP72, occurring 24 h following whole body HS-induced cardioprotection is limited. Since cardiac
events are usually associated with underlying cardiovascu-
lar diseases, it is important to study the development of the
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associated with endothelial [9] and myocardial [10,11] vein of rats anaesthetised with pentobarbital (D group).
dysfunctions. As a matter of fact, an altered sensitivity to Diabetes was conﬁrmed by the presence of glycosuria and
ischaemic injury has been observed in various models of polydypsia, detected 2 weeks after the STZ injection. Half
diabetes [12,13]. of the diabetic rats (DI group), randomly chosen, were
Furthermore, the cardioprotection, induced 24 to 48 h daily subcutaneously injected with 4 IU of insulin (Lente
following heat shock, resembles that observed during the MC, Novo, France) in the afternoon [21], 2 weeks after the
second window of protection following ischaemic pre- STZ injection. Age-matched control anaesthetised rats (V
conditioning [14–16]. When investigated in diabetic ani- group) were injected with the vehicle of the STZ (0.1 M
mals, ischaemic preconditioning has been reported to citrate buffer, pH 4.5). D and V groups were daily
reduce infarct size in a non-insulin-dependent diabetic rat subcutaneously injected with saline, 2 weeks after they
model in vivo [17]. Moreover, this preconditioning can received STZ or vehicle, respectively.
protect endothelial function in resistance coronary arteries After 8 weeks, D, DI and Vrats were submitted to either
of diabetic hearts [18]. On the other hand, Tosaki and heat stress (HS) or anaesthesia without hyperthermia
co-workers [19,20] have demonstrated that ischaemic (sham). All animals were allowed to recover for 24 h
preconditioning failed to reduce the incidence of ventricu- before their heart was isolated, perfused in the Langendorff
lar arrhythmias and to improve myocardial function of mode and submitted to an ischaemia (30 min)–reperfusion
diabetic rat hearts. (120 min) sequence.
Therefore, we investigated in this study whether heat Six experimental groups were studied: Group Sham-D
stress can afford protection against myocardial infarction (n56) – diabetic rats submitted to sham anaesthesia;
after an ischaemia–reperfusion sequence, in strep- Group Sham-DI (n56) – insulin-treated diabetic rats
tozotocin-induced diabetic rats, treated or not with insulin, submitted to sham anaesthesia; Group Sham-V (n56) –
and their age-matched controls. The heat stress-induction control rats submitted to sham anaesthesia. In groups HS-D
of cardiac HSP72 synthesis was also assessed in these (n56), HS-DI (n56) and HS-V (n56), rats were similarly
animals. treated prior to undergoing heat stress. The experimental
protocol is summarised in Fig. 1.
2. Material and methods 2.2. Heat stress protocol
2.1. Experimental groups Whole body hyperthermia was achieved as previously
described [22], by placing anaesthetised (with 25 mg/kg,
The care and use of animals in this work were in i.p. sodium pentobarbitone) D, DI or V animals in an
accordance with the Guide for the Care and Use of environmental chamber under an infra-red light. Their
Laboratory Animals published by the US National Insti- body temperature, recorded with a rectal probe, was
tutes of Health (NIH Publication No. 85-23, revised 1985). increased to 4260.28C for 15 min. Sham animals were
Male Wistar rats, weighing 240–270 g, were used. Dia- anaesthetised only. Rats were heat-stressed or sham-anaes-
betes was induced by a single injection of 55 mg/kg thetised in the morning, they received insulin or saline
streptozotocin (STZ, Sigma, France) [18] via the penian injection in the afternoon (as the day before) and were
Fig. 1. Experimental protocol.
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submitted to the ischaemia–reperfusion protocol the fol- ings were analysed for the incidence (%) of ventricular
lowing morning. tachycardia and/or ﬁbrillation (VT–VF) occurring during
ischaemia and reperfusion.
2.3. Ischaemia–reperfusion protocol
2.5. Determination of myocardial HSP72 content
Twenty-four hours after heat stress, the rats received
heparine (1000 U/kg, i.p.) and were anaesthetised with For myocardial HSP72 content determination, additional
sodium pentobarbitone (60 mg/kg, i.p.). Blood glucose animals (n52 or 3 per group) were submitted only to HS
concentration was then measured using an Accu-Chek or sham anaesthesia. Twenty-four hours later, D, DI or V
Glucose Monitor (Boehringer Mannheim). The heart was rats were anaesthetised (60 mg/kg sodium pentobarbitone,
rapidly excised and immediately immersed in 48C Krebs– i.p.), heparinised (1000 U/kg, i.p.) and their heart was
Henseleit buffer solution (NaCl 118.0, KCl 4.7, CaCl 1.8, 2 quickly excised as described in Section 2.3. Left ventricu-
KH PO 1.2, MgSO 1.2, NaHCO 25.2 and glucose 11.0 24 4 3 lar tissue samples (50 mg) were rapidly powdered in liquid
mM). The aortic stump was then cannulated and the heart nitrogen and suspended in 500 ml SDS–PAGE sample
perfused using the Langendorff technique at a constant buffer (20% glycerol, 6% sodium dodecyl sulphate, 1.4%
pressure (75 mm Hg) with oxygenated Krebs–Henseleit Tris–HCl, pH 6.8). 2-Mercaptoethanol (10%) was added
buffer. A water-ﬁlled latex balloon, coupled to a pressure and the samples were heated at 1008C for 10 min. Samples
transducer (Statham) was inserted into the left ventricular were cooled and centrifuged at 11 000 g for 5 min.
cavity via the left atrium for pressure recordings. Left Bromophenol blue (8%) was added to the supernatant and
ventricular end-diastolic pressure (LVEDP) was adjusted the samples were stored at 2208C. Proteins were separated
between 8–12 mm Hg. Myocardial temperature was mea- by electrophoresis on 12.5% polyacrylamide SDS–PAGE
sured by a thermoprobe inserted into the left ventricle and gels. Gels were stained in Coomassie blue R250 and
was maintained constant close to 378C. For temporary subsequently destained to conﬁrm equivalence of protein
occlusion of the left coronary artery (LCA), a 3/0 silk loading. For Western blot analysis of HSP72, proteins were
suture (Mersilk W546, Ethicon) was placed around the transferred electrophoretically onto nitrocellulose mem-
artery a few millimeters distal to the aortic root. After 20 brane (Hybond-C, Amersham, UK) overnight at 180 mA
min of stabilization, regional ischaemia was induced by and 48C. The membrane was placed in washing buffer for
tightening the snare around the LCA for 30 min [23]. 30 min (phosphate buffered saline, pH 7.2, containing
Thereafter the heart was reperfused for 120 min. Coronary 0.05% Tween 20 and 0.1% dried milk powder) to block
ﬂow (CF) was measured throughout the ischaemia–re- non-speciﬁc binding sites. The ﬁlter was ﬁrst incubated (60
perfusion procedure, by collecting the efﬂuent. Heart rate min) with a mouse monoclonal IgG cross-active to HSP72
(HR) and left ventricular developed pressure (LVDP5 (SPA-810, StressGen) at 1:1000 dilution and subsequently
difference between left ventricular systolic pressure and incubated (60 min) with horseradish peroxidase-conjugated
LVEDP) were continuously recorded on a polygraph rabbit anti-mouse IgG (P260, Dako, Denmark) at 1:2500
(Windograph, Gould Instrument). At the end of the dilution. The ﬁlter was developed using an enhanced
reperfusion period, the coronary artery ligature was retied chemiluminescence detection system (Amersham).
and unisperse blue dye (Ciba–Geigy, France) was slowly
infused through the aorta to delineate the myocardial risk
2.6. Statistical analysis zone. After removal of the right ventricle and connective
tissues, the heart was frozen and then cut into 2 mm
Arrhythmia incidences were compared using exact transverse sections from apex to base (six to seven slices/
Fisher’s tests. The other data are presented as mean6SEM. heart). Once defrosted, the slices were incubated at 378C
Comparisons of CF, HR and LVDP were determined by with 1% triphenyltetrazolium chloride (Sigma, France) in
repeated measures ANOVA. Hyperglycaemia, body phosphate buffer (pH 7.4) for 10–20 min and ﬁxed in 10%
weight, heart weight and infarct size were analysed by formaldehyde solution to distinguish clearly stained viable
one-way ANOVA with post-hoc multiple comparison tissue and unstained necrotic tissue. Left ventricular infarct
Tukey tests. p values #0.05 were considered signiﬁcant. zone (I) was determined using a computerised planimetric
technique (Minichromax; Biolab) and expressed as the
percentage of the risk zone (R) and of the left ventricle 2.7. Exclusion criteria
(LV).
Only hearts with CF within 8–15 ml/min and LVDP
2.4. Quantiﬁcation of arrhythmias .70 mm Hg at the end of the stabilization period were
included in this study. The efﬁciency of coronary occlu-
Arrhythmias were classiﬁed in accordance with the sion was indicated by a decrease in CF .30%. Hearts
Lambeth Conventions guidelines [24]. Electrogram record- which developed ventricular ﬁbrillation (VF) during is-
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Table 1 3.2. Haemodynamic data
Glycaemia, body weight and heart weight assessed in V (vehicle-treated),
D (STZ-treated) and DI (STZ plus insulin-treated) rats, 8 weeks after the
a Table 2 summarises CF, HR and LVDP data recorded in treatment
the six experimental groups during the stabilization and the
Group V D DI ischaemia–reperfusion. Twenty-four hours after heat stress
n5 12 12 12 or sham anaesthesia, a signiﬁcant bradycardia was ob-
Glycaemia (mg/dl) 130621 479612* 172626 served in diabetic hearts throughout the study. In DI
Body weight (g) 43366 27968* 45165
animals, the heart rate was not different with that of Vrats. Heart weight 3.3460.10 3.5160.14 3.2360.18
The other haemodynamic parameters did not differ be- (mg/g of body weight)
tween the six experimental groups. a Data are mean6SEM.
* p#0.05 vs. the other groups.
3.3. Arrhythmias data
chaemia–reperfusion that could not be restored to normal The incidence of ventricular arrhythmias during is-
sinus rhythm within 2 min were excluded [23]. chaemia and reperfusion periods is presented in Table 3.
Twenty-four hours after heat stress or sham anaesthesia,
there was no statistically signiﬁcant difference in VT–VF
incidence between the six experimental groups.
3. Results
3.4. Infarct size data
3.1. Glycaemia, body weight and heart weight in D, DI
and V rats Table 4 summarises infarct size data expressed as the
percentage of the risk zone (I/R) and of the left ventricle
Table 1 presents glycaemia, body weight and heart (I/LV) for the six experimental groups. Heat stress in-
weight values assessed in V, D and DI animals. In STZ- duced a 61% decrease of I/R in hearts from V animals
treated rats, glycaemia was signiﬁcantly higher than in whereas no protection was seen in D and DI hearts (p#
age-matched V rats whereas body weight was signiﬁcantly 0.001 by one-way ANOVA, Fig. 2). Similar results were
lower. In DI animals, 6 weeks of daily injection of insulin observed concerning the I/LV ratio (Table 4). Myocardial
rendered the glycaemia and the body weight comparable to risk size expressed as the percentage of the left ventricle
those of V rats. (R/LV) was similar for all groups (Table 4). Differences
Table 2
a,b Haemodynamic data, n56 in each group
Group Stabilization Ischaemia Reperfusion
5 min 29 min 15 min 30 min 60 min 120 min
CF Sham-V 10.560.9 4.460.3 3.660.6 6.960.6 6.360.5 5.360.6 4.160.4
(ml/min/ HS-V 11.260.8 5.460.7 4.660.7 7.060.7 6.160.7 5.760.7 4.060.6
g of heart) Sham-D 12.461.0 5.660.3 4.960.4 8.760.5 8.260.5 6.760.6 4.660.4
HS-D 10.361.3 5.061.0 4.460.9 7.661.3 6.761.2 5.161.1 3.460.9
Sham-DI 9.660.5 4.460.4 4.260.4 6.160.5 6.360.7 5.060.6 4.560.4
HS-DI 10.260.3 4.660.5 3.860.6 6.660.7 6.060.8 5.260.8 4.160.6
HR Sham-V 26867 24669 241611 24769 24069 23769 22366
(bpm) HS-V 29467 25867 25864 24865 24069 23468 22869
Sham-D 231613* 222610* 213611* 202612* 198613* 197613* 19069*
HS-D 227610* 21669* 21069* 195610* 193610* 193611* 18269*
Sham-DI 27766 25067 23966 23566 23069 22867 22267
HS-DI 29067 263610 238610 23068 22868 22866 22868
LVDP Sham-V 94653 3 656 0 667 3 666 8 676 4 675 3 66
(mm Hg) HS-V 83643 6 645 7 667 8 676 9 656 9 665 9 67
Sham-D 81632 9 635 0 677 5 666 4 645 2 634 3 63
HS-D 85694 3 625 3 646 6 610 55675 5 674 1 65
Sham-DI 92693 4 645 3 646 8 610 57694 9 674 0 65
HS-DI 86643 2 625 4 657 0 676 5 695 5 684 7 65
a CF – coronary ﬂow, HR – heart rate, LVDP – left ventricular developed pressure, Sham-V (vehicle-treated sham-anaesthetised rats), Sham-D
(STZ-treated sham-anaesthetised rats), Sham-DI (STZ plus insulin-treated sham-anaesthetised rats), HS-V (vehicle-treated heat-stressed rats), HS-D
(STZ-treated heat-stressed rats), HS-DI (STZ plus insulin-treated heat-stressed rats).
b Data are mean6SEM.
* p#0.001 vs. the other groups.
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Table 3
a,b Incidence (%) of ventricular tachycardia and or ﬁbrillations (VT–VF) during the ischaemia and the 120 min reperfusion periods
Group Sham-V HS-V Sham-D HS-D Sham-DI HS-DI
n5 66 6 6 66
VT–VF ischaemia 17 50 0 0 50 50
VT–VF reperfusion 67 100 100 33 50 83
a Sham-V (vehicle-treated sham-anaesthetised rats), Sham-D (STZ-treated sham-anaesthetised rats), Sham-DI (STZ plus insulin-treated sham-anaesthet-
ised rats), HS-V (vehicle-treated heat-stressed rats), HS-D (STZ-treated heat-stressed rats), HS-DI (STZ plus insulin-treated heat-stressed rats).
b Data are mean.
Table 4
a,b Risk (R) and Infarct (I) sizes expressed as a percentage of the left ventricle (LV)
Group Sham-V HS-V Sham-D HS-D Sham-DI HS-DI
n5 66 6666
R/LV(%) 49.761.0 51.461.1 52.060.6 51.860.9 52.260.6 50.660.6
I/LV (%) 14.661.5 6.161.0* 18.361.7 16.461.7 16.160.9 14.460.6
I/R (%) 30.063.2 11.762.0* 34.363.5 31.463.3 30.361.6 28.761.6
a Sham-V (vehicle-treated sham-anaesthetised rats), Sham-D (STZ-treated sham-anaesthetised rats), Sham-DI (STZ plus insulin-treated sham-anaesthet-
ised rats), HS-V (vehicle-treated heat-stressed rats), HS-D (STZ-treated heat-stressed rats), HS-DI (STZ plus insulin-treated heat-stressed rats).
b Data are mean6SEM.
* p#0.001 vs. all the other groups.
in infarct size, therefore, did not result from variability in
the risk zone.
3.5. HSP72 analysis
Western blot analysis of myocardial HSP72 content of
the six experimental groups is presented in Fig. 3. In V
animals, a marked increase in this protein was observed
following heat stress (HS-V vs. Sham-V groups). This
conﬁrms the adequacy of the heat stress protocol. This heat
stress-increase in HSP72 was also seen in the myocardium
of D (HS-D vs. Sham-D groups) and DI (HS-DI vs.
Sham-DI groups) rats.
4. Discussion
Fig. 2. Infarct size (I) expressed as a percentage of the risk zone (R) in
isolated rat hearts subjected to a 30 min coronary occlusion followed by In this study, we observed in non-diabetic rats that heat
120 min of reperfusion, from Sham-V (vehicle-treated sham-anaesthetised stress led to a delayed cardioprotection by signiﬁcantly
rats), HS-V (vehicle-treated heat-stressed rats), Sham-D (STZ-treated
reducing infarct size in the isolated heart subjected to an sham-anaesthetised rats), HS-D (STZ-treated heat-stressed rats), Sham-DI
ischaemia–reperfusion sequence, in accordance with previ- (STZ plus insulin-treated sham-anaesthetised rats), HS-DI (STZ plus
insulin-treated heat-stressed rats) groups. * p#0.001. ous in vivo [4,6] and in vitro [23,25] studies. We demon-
Fig. 3. Western blot analysis of myocardial HSP72 (72 kD) content in groups Sham-V (vehicle-treated sham-anaesthetised rats), HS-V (vehicle-treated
heat-stressed rats), Sham-D (STZ-treated sham-anaesthetised rats), HS-D (STZ-treated heat-stressed rats), Sham-DI (STZ plus insulin-treated sham-
anaesthetised rats), HS-DI (STZ plus insulin-treated heat-stressed rats). n52 or 3 per group.
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strated that this delayed resistance to myocardial infarction from transgenic ((mREN-2)27) hypertensive rats against
cannot be reproduced in a pathological rat model of infarction [34]. Here, we show that this heat stress-induced
insulin-dependent diabetes mellitus, even though the ani- protection is not seen in diabetic hearts, even though the
mals were treated with insulin. Moreover, myocardial animals were treated with insulin. It is difﬁcult to compare
HSP72 synthesis was enhanced by heat stress in both the protection induced by ischaemic preconditioning and
non-diabetic and diabetic animals. heat stress, since the end-point used in the studies [18,19]
Diabetes mellitus is often associated with cardiovascular was different. Furthermore, some could argue diabetic
complications, such as coronary artery disease and diabetic hearts might require a more extensive heat exposure to be
cardiomyopathy, resulting in an increased risk of myocar- protected. Unfortunately, this hypothesis is hard to verify
dial infarction and congestive heart failure [13,26]. More- because of the high lethality induced by a prolonged
over, the presence of diabetes dramatically reduces surviv- hyperthermia. Alternatively, it cannot be excluded that the
al after myocardial infarction even though the size of the window of protection might also be altered by diabetes and
infarct is not signiﬁcantly different compared to the non- further investigations are needed to explore this point.
diabetic population [12,13,27]. Hence, experimental Among the variety of myocardial abnormalities induced
therapies that protect healthy myocardium will be more by diabetes, increased protein kinase C activity has been
1 21 clinically relevant if they also protect the diabetic heart. reported [35], resulting in depressed Na –Ca exchanger
While clinical studies have demonstrated that diabetic activity [36]. It has also been shown that ATP-sensitive
hearts are more susceptible to ischaemic injury, studies potassium (K ) channels are altered in ventricular ATP
using experimental models of chemically-induced diabetes myocytes from diabetic rats [37,38]. Since activation of
have reported increased, decreased or unchanged sen- protein kinase C (PKC) and opening of K channels ATP
sitivities to ischaemia [12,13]. A possible explanation for appear to be crucial intermediate steps in the resistance to
this controversy could be a difference in the duration and myocardial infarction induced by heat stress [25,39], as
the severity of the diabetic state studied as well as in the well as by ischaemic preconditioning [40], it could be of
ischaemia–reperfusion protocol used. Thus, it seems that interest to explore if their alteration may explain the loss of
following 2–3 weeks of diabetes (induced by a ‘classical’ protection following these preconditionings. Other abnor-
dose of STZ) hearts develop resistance to ischaemia malities exhibited by diabetic myocardium, such as de-
11 whereas they became identically or more sensitive than the pressed Na –H activity [41], decreased sarcoplasmic
21 non-diabetic hearts following six and more weeks of reticular Ca pump activity [42] and altered antioxidant
diabetes [20,26,28]. In accordance with other studies using defences [43], may inﬂuence ischaemic injury and could
the same dose of STZ and the same duration of diabetes also be implicated.
[18,28,29], we have shown a comparable sensitivity to Another purpose of this study was to evaluate myocar-
ischaemia in diabetic and non-diabetic hearts since the dial HSP72 expression following hyperthermia, in non-
incidence of ventricular arrhythmias and the infarct size diabetic and diabetic rats, treated or not with insulin. In the
did not differ. absence of heat stress, our results show that there is a
In our isolated cardiac preparations, we observed that comparable small basal synthesis of this protein in hearts
STZ-induced diabetes is associated with a bradycardia from V, D and DI rats, suggesting that neither strep-
which is normalised by an insulin treatment, in accordance tozotocin nor insulin treatments affect the myocardial
with other studies [30,31]. This depression in basal sponta- HSP72 expression. Twenty-four hours following heat
neous pacemaker rate may result from changes in electro- stress, myocardial HSP72 expression was identically en-
physiological properties of sino-atrial node [30]. hanced in V, D and DI groups whereas only the V group
Among the experimental therapies that protect both was protected against infarction.
healthy and diabetic myocardium against ischaemic injury, Several studies point to a relationship between HSP72
adenosine-pretreatment or ischaemic preconditioning are induction and cardioprotection. Hence, Marber and co-
known [17,18,32]. However, Bouchard and Lamontagne workers [6] have observed that prior hyperthermia induces
[18] have shown that preconditioning must be more a high level of myocardial HSP72 expression along with
extensive and adenosine perfusion period be longer in the enhanced myocardial tolerance to ischaemic injury.
diabetic compared with non-diabetic hearts to achieve the Furthermore, the level of HSP72 has been correlated to the
same degree of endothelial protection. That possibly degree of heat stress-induced cardioprotection in the rat [7]
explains why Tosaki and his team [19,20] observed that and in the rabbit [8]. Finally, improved functional recovery
ischaemic preconditioning fails to protect diabetic rat has been observed in isolated perfused transgenic mice
hearts against ischaemia. In this study, we have investi- [44,45] and rat [46] hearts overexpressing HSP72 and
gated the potential cardioprotection of another experimen- subjected to an ischaemia–reperfusion sequence. However,
tal therapy, the heat stress. Few studies have explored the we have previously shown that infarct size reducing effect
myocardial protection induced by heat stress in pathologi- conferred by heat stress was abolished by both a -adreno- 1
cal models [33,34]. We have previously demonstrated that ceptor blockers [23] and PKC inhibitor [25] without
heat stress was able to protect hypertrophied myocardium changes in HSP72 induction, suggesting that other po-
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the development of a cardiomyopathy. Cardiovasc Res tential cytoprotective mechanisms or end-effectors could
1992;26:913–922. be implicated in this response. Since many crucial inter-
[11] Miller TB. Cardiac performance of isolated perfused hearts from
mediate steps (as PKC, K channels, antioxidant de- ATP alloxan diabetic rats. Am J Physiol 1979;236:808–812.
21 fences, sarcoplasmic reticular Ca pump [2]) of the heat [12] Paulson DJ. The diabetic heart is more sensitive to ischemic injury.
Cardiovasc Res 1997;34:104–112. stress-induced cytoprotection are altered in the diabetic
[13] Feuvray D, Lopaschuk GD. Controversies on the sensitivity of the myocardium, it is not surprising that this protection was
diabetic heart to ischemic injury: the sensitivity of the diabetic heart abolished in the diabetic heart although HSP72 synthesis to ischemic injury is decreased. Cardiovasc Res 1997;34:113–120.
was enhanced. On the other hand, altered gene regulation [14] Yellon MD, Baxter GF. A ‘second window of protection’ or delayed
preconditioning phenomenon: future horizons for myocardial protec- of another heat stress protein, the heme oxygenase-1 (also
tion? J Mol Cell Cardiol 1995;27:1023–1034. named HSP32) has been reported in cardiac tissues of
[15] Parratt JR, Szekeres L. Delayed protection of the heart against STZ-induced diabetic rats [47]. Further investigations are ischaemia. Trends Pharmacol Sci 1995;16:351–355.
required to clarify the signal transduction pathways which [16] Richard V, Kaeffer N, Thuillez C. Delayed protection of the
co-ordinate the heat stress response and the potential role ischemic heart – from pathophysiology to therapeutic applications.
Fund Clin Pharmacol 1996;10:409–415. of the different HSP in both non-diabetic and diabetic
[17] Liu Y, Thornton JD, Choen MV, Downey JM, Shaffer JR. Strep- hearts.
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